In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zentiva closes €84.8mm IPO

Executive Summary

In a five-times oversubscribed offering, generic drug company Zentiva BV has raised €84.85mm ($102.7mm) with a 5.6mm-share IPO, pricing its common shares at €15.24 ($18.36) apiece. The firm will trade on the Prague Stock Exchange; its global depositary shares (each of which equals one common share) will be listed on the London Stock Exchange. Zentiva's majority shareholder Warburg Pincus is selling $100mm in a secondary offering, leaving Pincus with a slightly over 50% stake in the company.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies